PHEX Genotype

If you grew up with bowed legs, short stature, unexplained dental abscesses, or a relative with a rare bone condition, this test can finally name what may have been happening in your body for years. A pathogenic variant in the PHEX gene is the genetic cause of X-linked hypophosphatemia (XLH), the most common inherited form of low phosphorus that quietly damages bones and teeth across a lifetime.

Confirming a PHEX variant changes what you do next. It opens the door to targeted therapy, smarter monitoring of bones, kidneys, and joints, and cascade testing for children, siblings, and parents who may carry the same variant without knowing it.

What PHEX Actually Does

PHEX (phosphate-regulating endopeptidase X-linked) is the instruction manual for a protein made mostly in bone- and tooth-forming cells. That protein helps regulate how much of a hormone called FGF23 (fibroblast growth factor 23) the body produces, though it does not directly break FGF23 down. FGF23 tells the kidneys how much phosphorus to keep versus pee out. When PHEX is not working, FGF23 climbs, the kidneys waste phosphorus, and bones and teeth lose the mineral they need to harden properly.

This is why people with PHEX variants tend to develop rickets in childhood and osteomalacia (soft bones) as adults, along with dental problems and joint changes, even when calcium and vitamin D look fine on a standard panel. Emerging research suggests PHEX also helps the parathyroid glands sense phosphorus, which may help explain why people with XLH often develop overactive parathyroid problems over time.

X-Linked Hypophosphatemia

XLH is the headline condition tied to PHEX. In a sponsored genetic testing program of 831 people with suspected genetic hypophosphatemia, PHEX variants were the most common finding (about 62% of those tested), and among individuals with a clinical diagnosis of XLH, roughly 82% were PHEX-positive. Hundreds of different loss-of-function variants have been catalogued across all parts of the gene, including nonsense, frameshift, splice, missense, and large deletion changes.

The clinical picture varies a lot, but in adult cohorts the long-term consequences are consistent: osteomalacia (the hallmark soft-bone disease of XLH), dental disease, nephrocalcinosis (calcium deposits in the kidneys), hearing impairment, and a high rate of orthopedic surgeries and joint replacements. Italian and Dutch cohorts of children and adults document delayed diagnosis as a recurring problem, with people often labeled "vitamin D-resistant rickets" for years before genetic testing clarified the cause.

Adult-Onset Bone Disease

PHEX variants are not just a pediatric story. Case reports describe adults presenting with hypophosphatemic osteomalacia that mimics tumor-induced osteomalacia, sometimes only diagnosed after extensive imaging fails to find a tumor. A novel loss-of-function variant (Ala720Ser) was identified in one such adult-onset case, and a 3'-UTR change has been linked to a familial adult-onset form.

If you have unexplained bone pain, fractures, or low phosphorus that doctors have struggled to explain, PHEX testing belongs in the workup, not as an afterthought.

Dental and Hearing Complications

In a study of 59 adults with confirmed PHEX mutations, dental abscesses, hearing impairment, and nephrocalcinosis were prominent features alongside skeletal disease. A Dutch cohort of 80 patients reported high prevalence of hearing loss, bone deformities, osteoarthritis, nephrocalcinosis, and hyperparathyroidism. These complications accumulate quietly over decades, which is why knowing about a PHEX variant early shapes surveillance for the rest of your life.

Why Severity Varies So Much

You might assume a more disruptive mutation means worse disease, but the evidence pushes back. A functional study of 53 children with XLH found no correlation between mutation type (truncating versus non-truncating) and disease severity. A separate Japanese cohort showed that severity tracks more closely with how much residual PHEX activity remains and whether key structural elements like the zinc-binding site stay intact, rather than with the mutation category alone.

Some 3'-UTR variants cause a uniquely mild form of XLH, especially in girls and women. In a retrospective case-control study, carriers of the c.*231A>G variant had higher phosphorus and more normal FGF23 levels than people with classic XLH. That same mildness can make this form hard to recognize without genetic testing.

Hidden Variants Standard Panels Can Miss

A negative first-pass genetic test does not always mean PHEX is innocent. Several families have been diagnosed only after researchers went looking for unusual variants: deep intronic changes that create new splice sites, a synonymous exon change that disrupts splicing, and large structural rearrangements. A Finnish family was eventually diagnosed using whole-genome sequencing and RNA studies after standard panels came back clean. A Danish family with a milder skeletal but more severe dental phenotype required deep intronic sequencing to find their PHEX variant.

If your clinical picture strongly suggests XLH but a standard PHEX panel is negative, advanced testing (whole-genome sequencing, MLPA, intronic sequencing) should be considered.

One-Time Result, Lifetime Action

PHEX is a germline genetic test. The result you get today is the result you would get next year, in a decade, and at the end of your life. There is no need to retest the gene itself unless variant call confidence is in question or a confirmatory method (such as Sanger sequencing after a SNP chip call) is needed.

What does need ongoing tracking is what your PHEX variant means downstream. If you carry a pathogenic variant, expect a long-term schedule of serum phosphorus, FGF23, parathyroid hormone, calcium, alkaline phosphatase, kidney imaging for nephrocalcinosis, dental exams, hearing checks, and bone assessments. The cadence depends on age, symptoms, and treatment, but at least annual monitoring of phosphorus and related labs is the floor for someone actively managing this condition.

What to Do With an Unexpected Result

A positive PHEX result should trigger several next steps. First, confirm the variant by an independent method if the initial test was a SNP chip or panel with limited coverage. Second, get a full mineral metabolism workup: phosphorus, FGF23, calcium, parathyroid hormone, vitamin D, and 24-hour urine phosphorus. Third, involve a metabolic bone specialist or endocrinologist familiar with XLH, because targeted therapy (the anti-FGF23 antibody burosumab) has changed the standard of care.

A genetic counselor should be in the loop before or after testing, especially if you are planning children. Because PHEX sits on the X chromosome, inheritance patterns matter: an affected father passes the variant to all his daughters and none of his sons; an affected mother has a 50% chance of passing it to each child regardless of sex.

What a Negative Result Does Not Tell You

A negative PHEX test does not rule out other genetic causes of low phosphorus or rickets. Validation of a next-generation sequencing panel covering PHEX and related phosphate-wasting genes showed that other genes (such as FGF23, DMP1, ENPP1, SLC34A3, SLC34A1, and CLCN5) can produce overlapping phosphate-wasting pictures. Mutations in CYP27B1 cause a mechanistically distinct disorder (vitamin D-dependent rickets type 1) rather than phosphate wasting, but it has also turned up in PHEX-negative individuals tested for hereditary rickets. If PHEX is negative but your phosphorus is low and your symptoms point toward a heritable cause, ask your clinician about a broader panel rather than stopping.

Who Should Test Family Members

Cascade testing of relatives is one of the highest-yield uses of a positive PHEX result. In family series, a large share of tested relatives carried the same variant, and many had milder or previously unrecognized symptoms. Early identification of an affected child or sibling can mean earlier treatment, less growth delay, and fewer irreversible skeletal deformities. This is one of the most concrete ways a one-time test changes the trajectory of multiple lives in a family.